论文部分内容阅读
52例成人急非淋白血病,均为初治者,用下述方案进行导诱缓解治疗,完全缓解的病例经巩固治疗后随机分2组,分别进行6个月及15个月的维持治疗,以比较其效果。定期作血液、骨髓、生化指标、骨髓细胞体外培养及白血病细胞分泌纤溶酶原激活因子的测定。诱导缓解方案:阿糖胞苷80mg/m~2/日,持续静滴1-5天;Vp16-213 80mg/m~2/日,静滴1-5天;
In 52 adult patients with acute non-leaf leukemia, all of them were newly diagnosed. The following programs were used to induce and induce remission. Completely relieved cases were randomly divided into 2 groups and maintained for 6 months and 15 months respectively. To compare its effects. Blood, bone marrow, biochemical markers, bone marrow cell culture in vitro, and plasminogen activator secreted by leukemia cells were routinely measured. Induced remission protocol: Cytarabine 80 mg/m~2/day, continuous intravenous drip for 1-5 days; Vp16-213 80 mg/m~2/day, intravenous drip for 1-5 days;